We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Court Rules in Favor of FDA Over Partial Clinical Hold of Vanda’s Tradipitant Study
The item has been added to your shopping cart.
Court Rules in Favor of FDA Over Partial Clinical Hold of Vanda’s Tradipitant Study
A U.S. court has ruled in favor of the FDA in a case filed by Vanda Pharmaceuticals alleging the agency didn’t provide an adequate scientific reason for a partial clinical hold issued in December 2018 for the company’s long-term study of tradipitant.